C. diff infection happens when the bacterium Clostridioides difficile multiplies in your gut, almost always after something has disrupted the normal balance of bacteria living there. Antibiotics are the single biggest trigger, making you up to 10 times more likely to develop an infection while taking them and for the month afterward. But antibiotics aren’t the whole story. Age, immune status, hospital exposure, and even the chemistry of your bile all play a role in whether C. diff takes hold.
The bacterium causes nearly half a million infections in the United States each year, and about 1 in 9 people who get it will have it come back within two to eight weeks. Understanding what sets the stage for infection can help you recognize when you’re most vulnerable.
Antibiotics Are the Primary Trigger
Your large intestine is home to hundreds of bacterial species that collectively keep opportunistic organisms like C. diff in check. Antibiotics don’t just kill the bacteria causing your infection. They sweep through the gut indiscriminately, thinning out protective species and opening ecological space for C. diff to flourish.
Not all antibiotics carry the same risk. The CDC identifies four classes as especially problematic: fluoroquinolones (commonly prescribed for urinary tract and respiratory infections), third- and fourth-generation cephalosporins (broad-spectrum drugs used for more serious infections), clindamycin, and carbapenems. These drugs tend to cause the most collateral damage to gut flora, which is why they show up disproportionately in C. diff cases. Longer courses of antibiotics can roughly double the risk compared to shorter courses.
The danger doesn’t end when you finish your prescription. The month after completing antibiotics is still a high-risk window because the gut microbiome hasn’t fully recovered. That’s why C. diff symptoms sometimes appear days or even weeks after the antibiotic course ends, catching people off guard.
How Your Gut Normally Fights C. Diff
The protective mechanism goes beyond simply having “good bacteria” crowding out the bad. A key battlefield is bile acid chemistry. Your liver produces primary bile acids that get modified by gut bacteria into secondary bile acids. These two types of bile acids have opposite effects on C. diff.
One primary bile acid, taurocholic acid, actually triggers C. diff spores to germinate and become active. Think of it as a wake-up signal. Healthy gut bacteria produce enzymes that break taurocholic acid down and convert it into secondary bile acids like deoxycholic acid, which powerfully inhibits C. diff growth. So in a healthy gut, the very substance that could activate C. diff gets neutralized before it causes problems. In studies, bacteria engineered to produce higher levels of these bile-converting enzymes reduced C. diff counts by roughly 70% in mice.
When antibiotics wipe out the bacteria responsible for this conversion, taurocholic acid accumulates. The result is a gut environment that actively encourages C. diff spores to wake up and multiply. This is also why fecal microbiota transplants work so well for recurrent infections: they reintroduce the bacterial communities that restore normal bile acid processing.
Who Is Most at Risk
Age is the strongest non-antibiotic risk factor. Adults 65 and older face significantly higher rates of infection and far worse outcomes. One in eight people in that age group who develop a healthcare-associated C. diff infection dies within a month, and more than 70% of all C. diff deaths occur in people over 65. The aging immune system, more frequent antibiotic use, and more time spent in healthcare settings all converge.
Other factors that raise your risk include:
- Weakened immune system: Cancer treatment, organ transplant medications, and other immunosuppressive therapies reduce your body’s ability to fight C. diff once it starts growing.
- Previous C. diff infection: Having had it before or being exposed to the bacterium makes you more susceptible to future episodes.
- Hospitalization or long-term care stays: These environments concentrate both the bacterium and the patients most vulnerable to it.
- Proton pump inhibitors (PPIs): Acid-reducing medications like omeprazole have been linked to slightly higher rates of C. diff, though the evidence isn’t strong enough to confirm they directly cause infection. Most people in those studies had other risk factors too.
C. Diff Spores and How They Spread
C. diff has a survival advantage that most gut bacteria lack: it forms spores. These tough, dormant structures resist heat, drying, and most common household cleaners. They persist on surfaces like bed rails, bathroom fixtures, and doorknobs long after an infected person has touched them. When you pick up spores on your hands and inadvertently swallow them, they travel to your colon, where they wait for the right conditions to activate.
Standard alcohol-based hand sanitizers don’t kill C. diff spores. Handwashing with soap and water is more effective because it physically removes them. For surface cleaning, chlorine bleach or EPA-registered disinfectants labeled for C. diff are necessary. Regular cleaning products won’t do the job. Hospitals use specialized protocols for rooms that housed C. diff patients, and if someone in your household has an active infection, bleach-based cleaning of shared bathrooms is important.
Carriers Without Symptoms
Not everyone who harbors C. diff gets sick. Studies estimate that 7 to 15% of healthy adults carry toxin-producing C. diff without any symptoms, though some research has found rates closer to 6 or 7% depending on the population studied. These asymptomatic carriers have enough protective gut bacteria to keep C. diff in check, but they can still shed spores and potentially spread the organism to more vulnerable people.
This distinction between colonization and active infection matters for testing, too. Molecular tests like PCR can detect C. diff DNA in people who aren’t actually infected, leading to overdiagnosis. That’s why labs often use a two-step approach, first screening for the presence of the organism and then testing specifically for the toxins it produces when causing active disease. Testing is only recommended when someone has unexplained diarrhea, not as a screening tool for people without symptoms.
Why Recurrence Is So Common
About 1 in 9 C. diff patients will have the infection return within two to eight weeks of their initial episode. Each recurrence makes the next one more likely, creating a frustrating cycle. The underlying reason ties back to the microbiome. The initial round of antibiotics damaged the gut flora, and the antibiotics used to treat the C. diff infection cause additional disruption. The gut never fully rebuilds its defenses before the remaining spores reactivate.
This is why treatment for recurrent C. diff has increasingly moved toward microbiome restoration rather than more antibiotics. Fecal transplants and newer microbiome-based therapies work by re-establishing the bacterial communities, and the bile acid chemistry they maintain, that keep C. diff suppressed long term.